Novel flavonoids with antiproliferative activities against breast cancer cells

Nianhuan Yao; Chao Yu Chen; Chun Yi Wu; Kiyomi Motonishi; Hsing Jien Kung; Kit S. Lam

doi:10.1021/jm101440r

Novel flavonoids with antiproliferative activities against breast cancer cells

Nianhuan Yao, Chao Yu Chen, Chun Yi Wu, Kiyomi Motonishi, Hsing Jien Kung, Kit S. Lam

Research output: Contribution to journal › Article › peer-review

41 Citations (Scopus)

Abstract

A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC₅₀ of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC₅₀ = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

Original language	English
Pages (from-to)	4339-4349
Number of pages	11
Journal	Journal of Medicinal Chemistry
Volume	54
Issue number	13
DOIs	https://doi.org/10.1021/jm101440r
Publication status	Published - Jul 14 2011
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Drug Discovery

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1021/jm101440r

Cite this

@article{185665d3d0f64b54a73758ff8884decc,

title = "Novel flavonoids with antiproliferative activities against breast cancer cells",

abstract = "A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.",

author = "Nianhuan Yao and Chen, {Chao Yu} and Wu, {Chun Yi} and Kiyomi Motonishi and Kung, {Hsing Jien} and Lam, {Kit S.}",

year = "2011",

month = jul,

day = "14",

doi = "10.1021/jm101440r",

language = "English",

volume = "54",

pages = "4339--4349",

journal = "Journal of Medicinal Chemistry",

issn = "0022-2623",

publisher = "American Chemical Society",

number = "13",

}

TY - JOUR

T1 - Novel flavonoids with antiproliferative activities against breast cancer cells

AU - Yao, Nianhuan

AU - Chen, Chao Yu

AU - Wu, Chun Yi

AU - Motonishi, Kiyomi

AU - Kung, Hsing Jien

AU - Lam, Kit S.

PY - 2011/7/14

Y1 - 2011/7/14

N2 - A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

AB - A series of flavone analogues were synthesized and evaluated for their antiproliferation activity against breast cancer cells. The IC50 of compound 10 and 24 were determined to be at 5 μM. These compounds were used as baits to screen breast cancer cDNA expression phage display proteome library. DNA sequencing of the binding phages suggests that eEF1A1 is a target protein for 10 and 24. Further optimization of these compounds led to the discovery of 39 with higher cytotoxic potency (IC50 = 1 μM) and binding to eEF1A2. Biological and biochemical data suggest that eEF1A2 might be a therapeutic target and that 39 is an excellent lead compound for further development.

UR - http://www.scopus.com/inward/record.url?scp=79960182468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960182468&partnerID=8YFLogxK

U2 - 10.1021/jm101440r

DO - 10.1021/jm101440r

M3 - Article

C2 - 21599001

AN - SCOPUS:79960182468

SN - 0022-2623

VL - 54

SP - 4339

EP - 4349

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

IS - 13

ER -

Novel flavonoids with antiproliferative activities against breast cancer cells

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this